Hoth Therapeutics stock rises after pipeline update
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hoth Therapeutics Inc (HOTH)
Assess today's live Hoth Therapeutics Inc (HOTH) share price, performance and insights using our live NASDAQ: HOTH stock exchange data.
Analyse the historical data and Hoth Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Hoth Therapeutics share price buy/sell indicators using real-time data (or discuss the Hoth Therapeutics (HOTH) stock price today with other investors in the Hoth Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ HOTH share price (ISIN: US44148G2049) to enhance your trading decisions with our free investment tools and resources.
What Is the Hoth Therapeutics Inc Share Price Today?
The Hoth Therapeutics share price today is 1.0700.
What Is the Stock Symbol for Hoth Therapeutics Inc
The stock symbol (or 'ticker') for Hoth Therapeutics Inc is "HOTH."
What Stock Exchange Does Hoth Therapeutics Inc Trade On?
Hoth Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Hoth Therapeutics Inc a Good Stock to Buy?
Determining whether Hoth Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Hoth Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Hoth Therapeutics share price buy/sell indicators using real-time data (or discuss the Hoth Therapeutics (HOTH) stock price today with other investors in the Hoth Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ HOTH share price (ISIN: US44148G2049) to enhance your trading decisions with our free investment tools and resources.
What Is the Hoth Therapeutics Inc Share Price Today?
The Hoth Therapeutics share price today is 1.0700.
What Is the Stock Symbol for Hoth Therapeutics Inc
The stock symbol (or 'ticker') for Hoth Therapeutics Inc is "HOTH."
What Stock Exchange Does Hoth Therapeutics Inc Trade On?
Hoth Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Hoth Therapeutics Inc a Good Stock to Buy?
Determining whether Hoth Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.0700
1.1200
52 wk Range
0.6554
3.8000
HOTH is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.07001.1200
52 wk Range
0.65543.8000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
HOTH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
5.0000
Upside
+367.29%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Hoth Therapeutics Company Profile
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It develops HT-001, a topical formulation in Phase II clinical trial for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-TBI to treat traumatic brain injury and ischemic stroke; HT-ALZ for the treatment and/or prevention of Alzheimer’s or other neuroinflammatory diseases; and HT-004 for treatment of asthma and allergies using inhalational administration. The company is developing BioLexa Platform, a proprietary, patented, drug compound platform in Phase I clinical trial for the treatment of eczema; and HT-005 for treating patients with lupus. The company has license agreements with the George Washington University; Isoprene Pharmaceuticals, Inc.; the North Carolina State University; Chelexa BioSciences, Inc. and the University of Cincinnati; Zylö Therapeutics, Inc.; and Voltron Therapeutics, Inc. The company was incorporated in 2017 and is headquartered in New York, New York.
Compare HOTH to Peers and Sector
Metrics to compare | HOTH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHOTHPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.4x | −2.0x | −0.6x | |
PEG Ratio | −0.05 | −0.02 | 0.00 | |
Price/Book | 2.0x | 0.7x | 2.6x | |
Price / LTM Sales | - | 4.6x | 3.2x | |
Upside (Analyst Target) | 367.3% | 229.5% | 41.8% | |
Fair Value Upside | Unlock | 6.5% | 5.1% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 5.0000
(+367.29% Upside)
Earnings
Latest Release
Nov 12, 2025
EPS / Forecast
-0.30 / -0.27
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Hoth Therapeutics (HOTH) Share Price Today?
The live Hoth Therapeutics share price today is 1.0700
What Stock Exchange Does Hoth Therapeutics (HOTH) Trade On?
Hoth Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Hoth Therapeutics?
The stock symbol (also called a 'ticker') for Hoth Therapeutics is "HOTH."
What Is the Current Hoth Therapeutics Market Cap?
As of today, Hoth Therapeutics market capitalisation is 16.60M.
What Is Hoth Therapeutics's (HOTH) Earnings Per Share (TTM)?
The Hoth Therapeutics EPS is currently -1.01 (Trailing Twelve Months).
Is HOTH a Buy or Sell From a Technical Analyst Perspective?
Based on today's Hoth Therapeutics moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Hoth Therapeutics Stock Split?
Hoth Therapeutics has split 1 times. (See the HOTH stock split history page for full effective split date and price information.)
How Many Employees Does Hoth Therapeutics Have?
Hoth Therapeutics has 3 employees.
What is the current trading status of Hoth Therapeutics (HOTH)?
As of 24 Dec 2025, Hoth Therapeutics (HOTH) is trading at a price of 1.0700, with a previous close of 1.1200. The stock has fluctuated within a day range of 1.0700 to 1.1200, while its 52-week range spans from 0.6554 to 3.8000.
What Is Hoth Therapeutics (HOTH) Price Target According to Analysts?
The average 12-month price target for Hoth Therapeutics is USD5, with a high estimate of USD5 and a low estimate of USD5. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +367.29% Upside potential.
What Is the HOTH Premarket Price?
HOTH's last pre-market stock price is 1.1000. The pre-market share volume is 4,680.0000, and the stock has decreased by -0.0200, or -1.7900%.
What Is the HOTH After Hours Price?
HOTH's last after hours stock price is 1.1100, the stock has decreased by 0.0400, or 3.7400%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.